Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Absoud

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
BMC Psychiatry|September 23, 2016
Guidelines for identification and treatment of individuals with attention deficit/hyperactivity disorder and associated fetal alcohol spectrum disorders based upon expert consensusSusan Young, Michael Absoud, Carolyn Blackburn, et al.
BMC Psychiatry|February 1, 2020
Clinical and cost effectiveness of a parent mediated intervention to reduce challenging behaviour in pre-schoolers with moderate to severe intellectual disability (EPICC-ID) study protocol: a multi-centre, parallel-group randomised controlled trialOlayinka Farris, Rachel Royston, Michael Absoud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance StudyAnu Goenka, Benedict D Michael, Elizabeth Ledger, et al.
BMJ Open|November 9, 2023
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trialMatilda Hill, Mildred Iro, Manish Sadarangani, et al.
Health Technology Assessment (Winchester, England)|February 8, 2024
Clinical and cost-effectiveness of an adapted intervention for preschoolers with moderate to severe intellectual disabilities displaying behaviours that challenge: the EPICC-ID RCTTamara Ondruskova, Rachel Royston, Michael Absoud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2012
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging featuresMichael Absoud, Ming J Lim, Wui K Chong, et al.
BMC Medicine|May 26, 2020
Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensusSusan Young, Jack Hollingdale, Michael Absoud, et al.
Frontiers in Psychiatry|April 5, 2021
Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus StatementSusan Young, Philip Asherson, Tony Lloyd, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 18, 2024
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromesEvangeline Wassmer, Charly Billaud, Michael Absoud, et al.
The Lancet. Child & Adolescent Health|August 6, 2021
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2Erika Molteni, Carole H Sudre, Liane S Canas, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
BMC Psychiatry|September 23, 2016
Guidelines for identification and treatment of individuals with attention deficit/hyperactivity disorder and associated fetal alcohol spectrum disorders based upon expert consensusSusan Young, Michael Absoud, Carolyn Blackburn, et al.
BMC Psychiatry|February 1, 2020
Clinical and cost effectiveness of a parent mediated intervention to reduce challenging behaviour in pre-schoolers with moderate to severe intellectual disability (EPICC-ID) study protocol: a multi-centre, parallel-group randomised controlled trialOlayinka Farris, Rachel Royston, Michael Absoud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance StudyAnu Goenka, Benedict D Michael, Elizabeth Ledger, et al.
BMJ Open|November 9, 2023
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trialMatilda Hill, Mildred Iro, Manish Sadarangani, et al.
Health Technology Assessment (Winchester, England)|February 8, 2024
Clinical and cost-effectiveness of an adapted intervention for preschoolers with moderate to severe intellectual disabilities displaying behaviours that challenge: the EPICC-ID RCTTamara Ondruskova, Rachel Royston, Michael Absoud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2012
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging featuresMichael Absoud, Ming J Lim, Wui K Chong, et al.
BMC Medicine|May 26, 2020
Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensusSusan Young, Jack Hollingdale, Michael Absoud, et al.
Frontiers in Psychiatry|April 5, 2021
Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus StatementSusan Young, Philip Asherson, Tony Lloyd, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 18, 2024
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromesEvangeline Wassmer, Charly Billaud, Michael Absoud, et al.
The Lancet. Child & Adolescent Health|August 6, 2021
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2Erika Molteni, Carole H Sudre, Liane S Canas, et al.
Pageof 8